DE2822751A1 - Cyclopentanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen - Google Patents

Cyclopentanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen

Info

Publication number
DE2822751A1
DE2822751A1 DE19782822751 DE2822751A DE2822751A1 DE 2822751 A1 DE2822751 A1 DE 2822751A1 DE 19782822751 DE19782822751 DE 19782822751 DE 2822751 A DE2822751 A DE 2822751A DE 2822751 A1 DE2822751 A1 DE 2822751A1
Authority
DE
Germany
Prior art keywords
formula
carbon atoms
compounds
group
gastric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19782822751
Other languages
German (de)
English (en)
Other versions
DE2822751C2 (enExample
Inventor
Michael Peter Lear Caton
Edward Charles John Coffee
Essex Grossbritannie Upminster
Gordon Leonard Watkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Publication of DE2822751A1 publication Critical patent/DE2822751A1/de
Application granted granted Critical
Publication of DE2822751C2 publication Critical patent/DE2822751C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE19782822751 1977-05-26 1978-05-24 Cyclopentanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen Granted DE2822751A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB22319/77A GB1581886A (en) 1977-05-26 1977-05-26 Prostanol derivatives

Publications (2)

Publication Number Publication Date
DE2822751A1 true DE2822751A1 (de) 1978-12-07
DE2822751C2 DE2822751C2 (enExample) 1988-01-28

Family

ID=10177472

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782822751 Granted DE2822751A1 (de) 1977-05-26 1978-05-24 Cyclopentanderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen

Country Status (9)

Country Link
US (1) US4158062A (enExample)
JP (1) JPS53147045A (enExample)
DE (1) DE2822751A1 (enExample)
FR (1) FR2392005A1 (enExample)
GB (1) GB1581886A (enExample)
HK (1) HK28784A (enExample)
IT (1) IT1094851B (enExample)
MY (1) MY8400370A (enExample)
SG (1) SG59183G (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0202112A1 (en) * 1985-05-15 1986-11-20 May & Baker Limited New pharmaceutical compositions

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH085794B2 (ja) * 1989-07-27 1996-01-24 株式会社上野製薬応用研究所 高脂質血症処置・血中脂質成分低下剤
JPH0769897A (ja) * 1993-09-01 1995-03-14 Green Cross Corp:The 血中トリグリセリド低下作用剤
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
JP4889219B2 (ja) * 2002-12-27 2012-03-07 スキャンポ・アーゲー 腹部不快感の処置のためのプロスタグランジン誘導体
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
US20090030072A1 (en) 2007-07-03 2009-01-29 Sucampo Ag Pharmaceutical combination of opioid and prostaglandin compound

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468830A (en) * 1974-01-26 1977-03-30 May & Baker Ltd Cyclopentane derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468830A (en) * 1974-01-26 1977-03-30 May & Baker Ltd Cyclopentane derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J.MARCH:Advanced Organic Chemistry, Reactions, Mechanisms and Structure, McGRAW-HILL, Kogakusha, Ltd., 1968, S.890 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0202112A1 (en) * 1985-05-15 1986-11-20 May & Baker Limited New pharmaceutical compositions

Also Published As

Publication number Publication date
HK28784A (en) 1984-04-06
JPS53147045A (en) 1978-12-21
IT1094851B (it) 1985-08-10
MY8400370A (en) 1984-12-31
IT7823915A0 (it) 1978-05-26
DE2822751C2 (enExample) 1988-01-28
GB1581886A (en) 1980-12-31
FR2392005B1 (enExample) 1980-04-04
SG59183G (en) 1984-07-27
JPS6151584B2 (enExample) 1986-11-10
FR2392005A1 (fr) 1978-12-22
US4158062A (en) 1979-06-12

Similar Documents

Publication Publication Date Title
DE2411382B2 (de) 2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung
DE2305092C2 (enExample)
DE2822751C2 (enExample)
DE2650845A1 (de) Neue spiro-(1,3-dioxolan-4,3')- quinuclidine
DE2636735A1 (de) 3-phenylspiro eckige klammer auf isobenzofuran-1,4'-piperidin eckige klammer zu sulfenamide und deren derivate
AT391320B (de) Piperazincarbonsaeure, ihre herstellung und diese enthaltende arzneimittel
DE2724478C2 (de) 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2632118A1 (de) Apovincaminolester und verfahren zu deren herstellung
DE1470074C3 (de) 1,2,3,4,6,7-Hexahydro-l lbH-benzo eckige Klammer auf a eckige Klammer zu chinolizine sowie deren Acetate und/oder phsiologisch verträgliche Säureadditionssalze sowie Verfahren zu ihrer Herstellung
DE1908545A1 (de) Verfahren zur Herstellung von neuen Thiepinderivaten
DE2502919C2 (de) Cyclopentan-Derivate, Verfahren zu ihrer Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen
DE2530515C2 (de) 4- bzw. 7-Hydroxy-4,5,6,7-tetrahydrothieno-[3,2-c] bzw.[2,3-c] pyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittelzubereitungen
DE1934392C3 (de) Neue 2-Pyridylthioamide und Verfahren zu ihrer Herstellung
DE3121175A1 (de) Erythro-1,2,3-triphenyl-1-pentanon-derivate sowie verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69124025T2 (de) Organosilan-Derivate, diese enthaltende pharmazeutische Mittel und Verfahren zu ihrer Herstellung
EP0001062B1 (de) Ergolin-Derivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Zusammensetzungen und ihre Anwendung bei therapeutischen Behandlungen
AT357555B (de) Verfahren zum herstellen von neuen spiro-(1,3- dioxolan-4,3')chinuclidinen, ihren salzen und isomeren
DE3237429A1 (de) Neue, gegebenenfalls an dem ring e substituierte derivate des 20,21-dinor-eburnamenins, verfahren und zwischenprodukte zu deren herstellung, deren verwendung als arzneimittel und die sie enthaltenden zusammensetzungen
AT237603B (de) Verfahren zur Herstellung von neuen o-Toluididen
AT214455B (de) Verfahren zur Herstellung von neuen phosphorhaltigen Indolderivaten
DE2003353B2 (de) Phenylisopropylaminoäthanol-Derivate, deren Herstellungsverfahren und Arzneimittel auf deren Basis
DE2935684A1 (de) 2-bromergosinin und seine saeureadditionssalze, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
DE1468681C3 (de) 17beta-Tetrahydropyranyloxy verbindungen der Androstanreihe sowie Verfahren zu ihrer Herstellung und Heilmittel
DE2421999C3 (de) Vincaminsäurederivate
EP0014996A1 (de) Heterocyclische spiroverknüpfte Amidine, ihre Stereoisomeren und optischen Isomeren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8380 Miscellaneous part iii

Free format text: SPALTE 1, ZEILE 4 "...13, 14-DIHYDRO-2-DES CARBOXY-..." AENDERN IN "...13, 14-DIHYDRO-2-DECARBOXY...."

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee